HSBC Holdings
PPH icon

HSBC Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History

HSBC Holdings’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,322
Closed -$1.39M – 3122
2024
Q1 		$1.39M Buy
+15,322
New +$1.34M ﹤0.01% 1650

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
FPGK
Financial Partners Group (Kansas) Overland Park, Kansas $836M AUM 21.04% 1-Year Est. Return

HSBC Holdings's PPH Position: Q2 2024 in Review

HSBC Holdings sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2024, closing a stake of 15,322 shares — an estimated $1.39M sold.

HSBC Holdings first reported a position in PPH in Q1 2024 and held it in 1 quarter. The position peaked at $1.39M in Q1 2024. 140 funds tracked by Wall St. Rank hold PPH as of Q2 2024.

  • HSBC Holdings reported no remaining VanEck Pharmaceutical ETF position as of Q2 2024 after selling out during the quarter.
  • HSBC Holdings sold 15,322 VanEck Pharmaceutical ETF shares in Q2 2024, an estimated $1.39M.
  • HSBC Holdings first reported a position in VanEck Pharmaceutical ETF in Q1 2024 and held it in 1 quarter.
  • HSBC Holdings's VanEck Pharmaceutical ETF position peaked at $1.39M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2024.

Based on HSBC Holdings's 13F filing for Q2 2024, filed 12 Aug 2024.